Ikgdar 100mg Injection
Images are for reference. Actual packaging may vary.
Rituximab (100mg)
Vial of 10 ml • Liquid
A valid prescription is required for this medicine.
Haven’t found an alternative? A health advisor can help you understand what to do next.
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
Rituximab binds to CD20 on B-cells, inducing apoptosis and mediating antibody-dependent cellular cytotoxicity.
Medical applications
Ikgdar 100mg Injection contains Rituximab, a chimeric monoclonal antibody targeting the CD20 antigen found on the surface of B-lymphocytes. It is indicated for the treatment of various B-cell malignancies, including non-Hodgkin’s lymphoma and chronic lymphocytic leukemia, as well as certain autoimmune disorders such as rheumatoid arthritis. Rituximab exerts its therapeutic effect by binding to the CD20 antigen, leading to B-cell depletion through mechanisms including antibody-dependent cellular cytotoxicity, complement-dependent cytotoxicity, and induction of apoptosis.
Ikgdar 100mg Injection is administered intravenously under strict medical supervision, with dosage and treatment schedules tailored according to the specific indication and patient response. Prior to infusion, premedication with antihistamines and corticosteroids is recommended to minimize infusion-related reactions. Patients should be monitored closely for adverse effects such as infusion reactions, infections, and hematologic toxicities.
Contraindications include known hypersensitivity to Rituximab or murine proteins. Caution is advised in patients with active infections or compromised immune systems. Ikgdar 100mg Injection should be used as part of a comprehensive treatment plan, with regular monitoring of clinical and laboratory parameters to assess efficacy and safety.
Monoclonal antibody (mAb)
Important precautions
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Ikgdar 100mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Ikgdar 100mg Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Ikgdar 100mg Injection may not be needed in these patients. Please consult your doctor.
Exercise Caution
It is not known whether Ikgdar 100mg Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
There is limited information available on the use of Ikgdar 100mg Injection in patients with liver disease. Please consult your doctor. Use of Ikgdar 100mg Injection is not recommended in patients with the active liver disease or those who had viral hepatitis as it can reactivate the infection.
Regular Checkup
0 reviews for Ikgdar 100mg Injection







